Description

Strategic Market Access professional with 7 years of global consulting experience. Proven ability to lead international research initiatives and translate complex payer and stakeholder feedback into actionable market access, pricing and commercial strategies. Experienced in driving market access strategy across the full product lifecycle, including cross-functional alignment and delivering insight-driven recommendations to senior stakeholders.

Industry field of expertise

Languages

English
Native or bilingual

Workplace preferences

Remote only

Primarily works remotely

Access Infinity – Global Pricing & Market Access Consulting,
Senior Consultant
August 2022 - February 2025 (2 years and 6 months)
London, UK
Led consulting projects for global pharma clients (including Takeda, Janssen, Pfizer, Regeneron, Amgen) across therapy areas such as Oncology, Nephrology, Immunology, Neurology, and rare diseases.

Designed and executed pricing and market access strategies for pipeline and launch-stage products in North America, Europe, Asia-Pacific, and Latin America.

Conducted 400+ payer and KOL interviews to gather insights on product positioning, evidence needs, and reimbursement pathways, translating findings into actionable launch plans.

Created market-specific access playbooks, objection handling tools, and value communication materials for affiliates to support payer negotiations and submissions.

Collaborated closely with cross-functional teams to align evidence generation, value proposition, and market access strategy across global, regional, and local levels
Wickenstones – Market Access Consulting,
Associate
February 2021 - August 2022 (1 year and 6 months)
Oxford, UK
•Managed market access and pricing projects for global and regional P&MA teams, delivering strategies for assets in Oncology, Endocrinology, Cardiology, and rare diseases.

Developed payer value messaging, launch access strategies, and training resources for affiliate market access teams.

Led onboarding and capability development programmes for new graduates, focusing on HTA processes, EU4/UK/US payer systems, and market-specific policy updates.

Provided strategic input on reimbursement requirements and contracting options in multiple markets.
Evidera – Market Access Consulting,
Senior Analyst
October 2019 - February 2021 (1 year and 4 months)
London, UK
Delivered global market access support including pricing strategy, HTA landscape analysis, and evidence gap assessment across North America, Europe, and Latin America.

Monitored and communicated global pricing and reimbursement policy changes as part of the Market Access Centre of Excellence.

Supported value proposition development and launch planning through research, data synthesis, and stakeholder engagement.

Contributed to payer insight reports used to inform client launch readiness and post-launch market strategies.